61st General Assembly of the Hungarian Society for Laboratory Diagnostics

Budapest, 08-10 June, 2023

Current domestic events / 61st General Assembly of the Hungarian Society for Laboratory Diagnostics

Dear Colleagues!

I cordially and respectfully invite you to the 61st Annual General Meeting of the Hungarian Society of Laboratory Diagnostics 2023, which will be held between 8-10 June 2023 at Semmelweis University.

FINALLY, after a break of five years (!), we will have the opportunity to meet again with a real presence, to exchange experiences and to give new impetus to our contacts.

Five years is a long time, especially in a profession as dynamic and evolving as laboratory diagnostics. Especially at a time when the external environment is challenging and unpredictable. The demands placed on laboratories have changed dramatically. New concepts, measurement principles and systems have emerged. In addition, there are more and more reports about the introduction of a radically new laboratory organisation principle in Hungary.

Technology has made virtual communication possible. Two-dimensional, or in better cases black-squared, online conferences ensure the dissemination of information, but this has not replaced the real experience of three-dimensional encounters. The congress now offers a space for face-to-face meetings, socialising and conversations.

The main themes of the Congress:

Organisation of NOLD (National Network of Medical Laboratory Diagnostics)
Pre- and post-analytical issues in laboratories
Pre-analytical and pre-analytical aspects of the post COVID era
Analysis of “liquid biopsy” samples
The importance of microbiome testing
Varia session

Of course, abstracts are still welcome this year, with a deadline of 31 March 2023. For more information on abstract submission, please also visit the website.

Information on the opening of registration will be sent out in a further letter.

The cost of providing the Congress facility will increase dramatically. Therefore, the participation fee for this event, like any other similar social event, will increase significantly compared to previous years. We ask for your understanding in this respect and hope that, despite the higher costs, you will decide that the personal contacts and the opportunity for professional development are worth the investment.

We look forward to your participation.

With collegial greetings:

Dr. Barna Vásárhelyi Dr. Attila Miseta Dr. János Kappelmayer
president of the congress MLDT president Chairman of the Scientific Committee

Date: 8-10 June 2023.

Location: Budapest, Nagyvárad Square Theoretical Block – Semmelweis University

IMPORTANT DATES

Opening of registration: coming soon
Discounted registration deadline: coming soon
Abstract submission deadline: 31 March 2023.
Abstract deadline: 30 April 2023.
Notification of abstract submitters: 5 May 2023.

REGISTRATION FEES

MLDT and/or MOLSZE members: 55.000 HUF
Retired MLDT and/or MOLSZE members: 50.000 Ft
For non-members: 60.000 Ft
For company members: 55.000 Ft

The participation fee includes the participation in the scientific programme, the right to visit the professional exhibition, the programme booklet, accreditation points, participation in the coffee breaks and the Thursday dinner, as well as VAT. The value of the coffee breaks and the Thursday dinner will be indicated on the invoice as a catering service. The gross amount of the participation fee for the meals is 38.000 HUF, which will be shown on the Advances invoice under the heading PREPAYMENT with a VAT code of 27%. The actual VAT rates will be clarified/decided on the final invoice issued after the event with 5% and 27% VAT rates.

For PHD students and residents: 30.000 HUF

The participation fee includes participation in the scientific programme, the right to visit the professional exhibition, the programme booklet, accreditation points, participation in coffee breaks and VAT. The value of the coffee breaks will be indicated on the invoice as a catering service. The participation fee for the meals is 21.500 HUF gross, which will be indicated on the Prepayment Account under the heading PREPAYMENT with a VAT code of 27%. The actual VAT rates will be clarified/decided on the final invoice issued after the event with 5% and 27% VAT rates.

Day ticket: 35.000 Ft

The participation fee for day ticket holders includes participation in the scientific programme of the day, the right to visit the professional exhibition, the programme booklet, accreditation points and participation in the coffee breaks on the day. The value of the coffee breaks will be indicated on the invoice as a meal service. The participation fee for meals is HUF 10,000 gross, which will be shown on the Advances invoice under the heading PREPAYMENT with a VAT code of 27%. The actual VAT rates will be clarified/decided on the final invoice issued after the event with 5% and 27% VAT rates.

Accompanying person: 45.000 Ft

The accompanying person’s participation fee includes participation in the dinner on Thursday and Friday and VAT. The value of the dinners will be shown on the invoice as meals provided through an intermediary. The gross amount of the participation fee for the meals is 45.000 HUF, which will be indicated on the Prepayment Account under the heading PREPAYMENT with a VAT code of 27%. The actual VAT rates will be clarified/decided on the final invoice issued after the event with 5% and 27% VAT rates.

Helyszín: Budapest, Nagyvárad téri Elméleti Tömb – Semmelweis Egyetem

2023. június 8. csütörtök

11.00-12.00 ÜNNEPÉLYES MEGNYITÓ (helyszín: Nagyvárad tér Díszterem)

A Nagygyűlés résztvevőit üdvözlik:

Merkely Béla, a Semmelweis Egyetem rektora
Miseta Attila, az MLDT elnöke
Vásárhelyi Barna, az MLDT-61 konferencia elnöke
Mario Plebani: Welcome address by the EFLM President-Elect
Péterfalvi Ágnes, az MLDT titkára – Pándy emlékérem / Somogyi emlékérem díjazottak ismertetése, laudációk

12.00-12.30 Jendrassik-díjazott előadása (helyszín: Nagyvárad tér Díszterem)
Laudáció: Péterfalvi Ágnes, az MLDT titkára

PL1 Advances in biomarker research: assay developments and clinical evaluations Kőszegi Tamás
Department of Laboratory Medicine, University of Pécs, Medical School, Pécs, Hungary

12:30-13:00 Plenary lecture I. (helyszín: Nagyvárad tér Díszterem)
Üléselnökök: Kovács L. Gábor – Ajzner Éva

PL2 Sustainability in laboratory medicine
Mario Plebani
Department of Clinical Biochemistry and Clinical Molecular Biology, University of Padova, Padova, Italy

13:00-14:00 Ebédszünet (helyszín: Nagyvárad tér, előcsarnok)

14:00-14:45 Plenary lecture II. (helyszín: Nagyvárad tér Díszterem)
Üléselnökök: Kappelmayer János – Kőszegi Tamás

PL3 The future of clinical laboratories between centralized and decentralized testing
Mario Plebani
Department of Clinical Biochemistry and Clinical Molecular Biology, University of Padova, Padova, Italy

14:50-15:00 Műszerkiállítás megnyitása (helyszín: Nagyvárad tér Aula)
Megnyitja Vásárhelyi Barna, az MLDT-61 konferencia elnöke

SZÜNET

15:15-16:45 Extra-analitikai szekció (helyszín: Nagyvárad tér Díszterem)
Üléselnökök: Miseta Attila – Vásárhelyi Barna

SE1.1 Evaluation of body fluids based on a new laboratory algorithm
Hevessy Z., Kürti-G Szabó E.
Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

SE1.2 Risk management in post-post analytical processes
Szlatinszki N. Barna T.K.¹, Csernák Z.².
¹SYNLAB Laboratory, Dunaújváros, ²SYNLAB Hungary Ltd., Budapest, Hungary

SE1.3 Estimated glomerular filtration rate: which equation should we use?
Szakony S., Kacz-Buzer K., Süki N.
St. Imre Teaching Hospital, Central Laboratory, Budapest, Hungary

SE1.4 Practice of lipid result reporting in Hungary and introduction of a new report format at the University of Debrecen
Tóth J.¹, Harangi M.², Paragh G.², Kassai P.³, Szakács Szilágyi E.¹, Kalina E.¹, Kappelmayer J.¹
¹University of Debrecen, Department of Laboratory Medicine, Debrecen, Hungary, ²University of Debrecen, Department of Internal Medicine, Debrecen, Hungary, ³ESZFK Nonprofit Kft, Budapest, Hungary

SE1.5 Quo vadis, LDL Cholesterol?
Nagy T., Hevesi J., Simon J.
Central Hospital of Northern Pest – Military Hospital, Budapest, Hungary

SE1.6 How has the pandemic affected our everyday laboratory work?
Farkas K., Araczki Á., Földesi I.
University of Szeged, Institute of Laboratory Medicine, Szeged, Hungary

16:45-17:00 SZÜNET

17:00-17:10 Beckman Coulter újgenerációs immunkémiai automata bemutatása – DxI9000 Access Immunassay (helyszín: Nagyvárad tér Aula)

17:15-18:30 COVID-19 és Post-COVID laborvonatkozásai szekció (helyszín: Nagyvárad tér Díszterem)
Üléselnökök: Bekő Gabriella – Nagy Tamás

SE2.1 Clinical microbiological evaluation of respiratory multiplex PCR test results during the pandemic
Kristóf K., Juhász E., Iván M., Károlyi S., Szabó E., Farkas P., Székely K., Sluch M.
Semmelweis University, Institute of Laboratory Medicine, Budapest, Hungary

SE2.2 Correlations between post-COVID-19 syndrome, humoral and T-cell immune responses
Bekő G., Uher F.¹, Matula Z.¹, Gönczi M.¹, Zóka A.¹, Balázs ^T.2, Papp S.², Bacskai M.²
¹Central Hospital of Southern Pest-National Instituter of Hematology and Infectious Diseases, Budapest, Hungary, ²Healtware Consulting Ltd, Budapest, Hungary

SE2.3 Examination of Anti-SARS-CoV-2 induced humoral immune response among healthcare professionals of the Albert Szent Györgyi Clinical Center
Szilasi T. J. Farkas K., Araczki Á., Földesi I.
University of Szeged, Department of Laboratory Medicine, Szeged, Hungary

SE2.4 Cellular responses against SARS-CoV-2 after 1 year of the 3rd dose of BNT162b2 mRNA homologous vaccinations in healthcare workers measured by the new Roche IGRA-test
Nagy B Jr., Nagy M., Nagy-Koronai Á., Szakács Szilágyi E., Pócsi M., Kappelmayer J.
Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

SE2.5 Prognostic value of pro-inflammatory cytokines in severe acute multisystem inflammatory syndrome in children
Bartha-Tatár A.¹, Sinkovits G.², Szalay B.³, Biro E.³, Bekő G.³, Varga P.⁴, Szabó T.⁴, Fagyas M.1, Prohászka Z.², Kappelmayer J.¹, Nagy B. Jr.¹
¹Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; ²Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary; ³National Institute of Hematology and Infectious Disease, Budapest, Hungary; ⁴Institute of Pediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

19:00-20:30 NYITÓFOGADÁS (helyszín: Nagyvárad tér Galéria)

2023. június 9. (péntek)

Párhuzamos szekciók:

9.00-10.30 Hemosztázis rendellenességek (helyszín: Nagyvárad tér, Díszterem)
Üléselnökök: Kappelmayer János – Bereczky Zsuzsanna

SE3.1 Value of next-generation sequencing in the diagnosis of platelet function disorders
Gindele R.¹, Kerényi A.², Szűcs Z.², Madar L.², Szabó Z.¹, Balogh I.², Bereczky Z.¹
¹Division of Clinical Laboratory Science, Department of Laboratory Medicine, ²Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

SE3.2 Investigation of platelet activation in severe COVID-19 disease
Balla G., Pócsi M., Sütő R., Fejes Z., Kappelmayer J., Nagy B. Jr.
Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

SE3.3 Technical and clinical validation of the measurement of apixaban and rivaroxaban, direct-thrombin inhibiting oral anticoagulants in dried blood microsamples.
Vincze I., Fehér A., Domján G., Karvaly G.
Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary

SE3.4 Alterations of fibrinolysis in SARS-CoV-2 infected pregnant women: a prospective, case-control study
Orbán-Kálmándi R.¹, Tóth E.², Molnár É.¹, Lóczi L.¹, Deli T.², Török O.², Molnár S.², Tóth J.1, Krasznai Z.², Bagoly Z.¹
¹University of Debrecen, Department of Laboratory Medicine, Division of Clinical Laboratory Sciences, Debrecen, Hungary, ²University of Debrecen, Department of Gynecology and Obstetrics, Debrecen, Hungary

SE3.5: Examination of pathogens isolated from respiratory tract and blood culture samples of patients with SARS-CoV-2 infection
Kalmár K.
Central Laboratory of Szent Erzsébet Hospital, Jászberény, Hungary

SE3.6 Effect of SARS- CoV-2 mRNA vaccination on the balance of hemostasis in children with inflammatory bowel disease
Hodossy-Takács R.¹, Stercel V.², Lóczi L.^1, Kadenczki O.², Nemes É.², Szabó T.², Bagoly Z.¹
¹University of Debrecen, Faculty of Medicine, Division of Clinical Laboratory Sciences, Debrecen, Hungary, ²University of Debrecen, Faculty of Medicine, Department of Pediatrics, Debrecen, Hungary

9.00-10.15 Gyógyszerszint meghatározás-Gyógyszerhatások laborvonatkozásai (helyszín: VIP Páholy)
Üléselnökök: Földesi Imre-Markó Eleonóra

SE4.1 Drug level monitoring of biological therapeutic agents in IBD
Kovács K.1, Stachmann R.¹, Szőkéné R.¹, Cseh Á.²
¹Semmelweis University, Department of Laboratory Medicine, Budapest, Hungary, ²Semmelweis University, Department of Pediatrics, Budapest, Hungary

SE4.2 Therapeutic monitoring of oral oncological drugs with cellular protein targets for supporting personalized treatments
Köllő Z.¹, Vincze I.¹, Kovács J.², Garami M.², Karvaly G.¹
¹Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary, ²Department of Pediatrics, Semmelweis University, Budapest, Hungary

SE4.3 In silico nonparametric population pharmacokinetic models for monitoring piperacillin exposure in critically ill adult patients
Karvaly G.¹, Vincze I.¹, Czermann R.², Farkas R.¹, Kopitkó C.²
¹ Semmelweis University, Department of Laboratory Medicine, Budapest, Hungary, ² Uzsoki Street Hospital, Central Department of Anaesthesiology and Intensive Care, Budapest, Hungary

SE4.4 High-throughput therapeutic drug monitoring of beta-lactam antibiotics, beta-lactamases, and linezolid using liquid chromatography-tandem mass spectrometry
Farkas R., Csöndör É., Bocskai K., Chriszt B., Karvaly G.

Semmelweis University, Department of Laboratory Medicine, Budapest, Hungary
SE4.5 Laboratory diagnostic pitfalls of sarcoidosis due to angiotensin-converting enzyme (ACE) inhibitor treatment
Szabó A.Á., Enyedi E.E., Altorjay I.T., Váradi C., Pintér T.B., Fagyas M.
Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

SZÜNET

10.45-11.15 Siemens szimpózium: New Atellica CI 1900 Analyzer (Helyszín: Nagyvárad tér, Díszterem)
SY1.1 The power and possibility of the central laboratory in every clinical environment
Szalma Anikó
Diagnosticum Zrt.

SZÜNET

11:30-12:00 Abbott szimpózium: HPV Primary Screening – Europe experience (Helyszín: Nagyvárad tér, Díszterem)

SY1.2 Diana Winter (Country Manager Emerging Markets, Abbott): National HPV Primary Screening programs for prevention of cervical cancer – Europe experience. Abbott Alinity m HPV solution for HPV screening

12:00-13.15 EBÉDSZÜNET, MŰSZERKIÁLLÍTÁS MEGTEKINTÉSE

Párhuzamos szekciók:

13:15-14:35 POSZTERSZEKCIÓ I. (Helyszín: Nagyvárad tér, Tanácsterem)
PS1.1-16 Poszterzsűri: Ajzner Éva, Nagy Béla

PS1.1 Methodological comparison of the detection of APC resistance by Pefakit® APC-R Factor V Leiden and STA-STACLOT® APC-R
Domokos L., Ónody R., Váradi A., Kiss A., Földesi I.
University of Szeged Albert Szent-Györgyi Health Centre, Institute of Laboratory Medicine, Szeged, Hungary

PS1.2 Mononucleosis like morphology in hepatitis E virus infection
Szénásy D., László K.
SYNLAB Laboratory Székesfehérvár, Székesfehérvár, Hungary

PS1.3 Myelodysplasia with mast cells
¹László K, ²Sánta H., ²Bátai Á.
¹SYNLAB Laboratory Székesfehérvár,²Department of Hematology, Szent György Hospital, Székesfehérvár, Hungary

PS1.4 Examination of CD16+ monocyte ratios in Chronic Critical Ill patients of the Intensive Care Unit. A case study of 3 patients
Vass K.C.¹, Szabó Z.¹, Kárpáthi I.K.2
¹Semmelweis University, Department of Laboratory Medicine, ²Semmelweis University, Department of Anesthesiology and Intensive Care, Budapest, Hungary

PS1.5 Applicability of red blood cell parameters determined by Sysmex optical method in case of blood samples with cold agglutinins
Papp E., Tisza K., Jéghné L.M., Tárnoki G., Tömöri B., Bekő G. Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary

PS1.6 The importance of hemostasis screening tests based on case studies
Fazekas D., Várnai K., Gürtler F., Méri A., Simon J.
North-Pest Center Hospital – Military Hospital, Central Department of Laboratory Diagnostics, Budapest, Hungary

PS1.7 Extreme hematology results in routine laboratory work obtained on Sysmex XN 1000 Hematology Analyser: three special case studies
Kispál R.P.¹, László K.², Érckövi É.¹
¹SYNLAB Laboratory Kiskunhalas, Kiskunhalas, Hungary, ²SYNLAB Laboratory Szekesfehervar, Székesfehérvár, Hungary,

PS1.8 The use of DIC panel in young patients with severe infection
Bertalan T.Á., Vajda Z.
Semmelweis University, Department of Laboratory Medicine, Budapest, Hungary

PS1.9 Establishing an algorithm for the objective management and reporting of fragmentocytes in the peripheral blood
Jakobicz E., Mandrik K., Farkas K., Trucza É.G., Berecz E., Földesi I.
Department of Laboratory Medicine, University of Szeged, Szeged, Hungary

PS1.10 The effect of anticoagulant therapy on laboratory findings (Case presentation)
Szűcs Z., Zemlényi G., Varga R., Gilányi I., Fodor B.
B-A-Z County Hospital, Miskolc, Hungary

PS1.11 Changes in hemostasis parameters in a patient who underwent liver transplantation: a case report
Kulcsár R.G., Bárdos Papp A., Smudla A., Varga M.
Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary

PS1.12 Comparison of column agglutination with the automated blood bank system IH-500 and reference tube method for blood group antibodies titration
Frankó Z.¹, Süle A.², Nemes Nagy Z.¹, Soós Z.¹, Varga L.¹
¹Hungarian National Blood Transfusion Service, Budapest, Hungary
²Bio-Rad Magyarország Kft., Budapest, Hungary

PS1.13 Exploration of hereditary haematological malignancies (HMM)
Varga L., Csabán D., Őrfi Z., Tankó L., Bors A., Harasztdombi J., Dolgos J., Reichardt J., Koller B., Fábián J., Várkonyi A., Lakatos V., Gopcsa L., Vályi-Nagy I., Reményi P., Andrikovics H.
Central Hospital of Southern Pest, Budapest, Hungary

PS1.14 Comparison of our routinly used APTT reagents
Vilimi B., Király V., Bekő G.
Central Hospital of Southern Pest, National Institute of Haematology and Infectious Diseases, Budapest, Hungary

PS1.15 The negative predictive value of D-Dimer in medical practice
Sipos L., Könczöl P.
Synlab Hungary Ltd., Székesfehérvár, Hungary

PS1.16 Comparative studies for cell counting of body fluids by automated and manual methods
Kürti G.-Szabó E, Hevessy Z.
Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

13:15-14:35 POSZTERSZEKCIÓ II. (Helyszín: Nagyvárad tér, Tanácsterem)
PS2.1-16 Poszterzsűri: Fodor Bertalan, Kocsis Andrea

PS2.1 A comparison between an enzyme-linked immunosorbent assay and immunoradiometric method for chromogranin A measurements
Gonda J., Mező-Géresi K., Huszár K., Simon J.
North-Pest Center Hospital – Military Hospital, Central Department of Laboratory Diagnostics, Budapest, Hungary

PS2.2 Measurement of total serum bile acid concentrations: based on 1 year of experience there is a need for the establishment of own reference ranges
Kocsis I., Molnár-Világos G., Sörös B.
Central Laboratory, Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary

PS2.3 Diagnostic significance of inflammatory markers in severe septic patients – case report
Biró E., Szalay B., Bekő G.
Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Central Laboratory, Budapest, Hungary

PS2.4 A potential role of suPAR in COVID-19 infections
Szalay B.¹, Biró E.¹, Bacskai M.², Balázs T.², Papp S.², Bekő G.¹
¹Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Central Laboratory, Budapest, Hungary
²Heathware Consulting Ltd, Budapest, Hungary

PS2.5 Our experience in testing asparaginase enzyme activity
Szőkéné R.¹, Stachmann R.¹, Kovács K.¹, Erdélyi D.², Imreh É.¹
¹Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary, 2Department of Pediatrics, Semmelweis University, Budapest, Hungary

PS2.6 Comparison of the LDL-cholesterol levels calculated using the Martin-Hopkins and the Friedewald methods in patients after acute coronary syndrome
Tajtiné Fazekas K.,¹ Dani G.,² Márk L.³
¹Békés County Central Hospital, Pándy Kálmán Branch, Central Laboratory, ³Department of Cardiology, Gyula; ²Town Hospital, Orosháza, Hungary

PS2.7 Serum human epididymis protein 4 (HE4) predicts disease severity and mortality in hospitalized patients with severe COVID-19
Sütő R., Pócsi M., Fejes Z., Kappelmayer J., Nagy B. Jr.
Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

PS2.8 Measurement of hemoglobin A1c: comparison of two different methods and availability of the results in clinical decision making
Gyuris K.G^1,2, Valczer E.², Földesi I.²
¹Dr. László Elek Hospital and Clinic, Central Laboratory, Orosháza, Hungary, ² University of Szeged, Albert Szent-Györgyi Health Centre, Institute of Laboratory Medicine, Szeged, Hungary

PS2.9 Investigation of glucose-6-phosphate dehydrogenase activity in Hungary
Fejes Z., Hasulyó A., Kürti G.-Szabó E., Ivády G., Mezei Z., Hevessy Z., Kappelmayer J.
Department of Laboratory Medicine, Faculty of Medicine, University of Medicine, Debrecen, Hungary

PS2.10 Errors arising from preanalytical and analytical factors in the assessment of thyroid function presented by a case report
Toldy E.^1,2, Konderák J.¹, Kispál R.P.¹, Lőcsei Z.³, Góth M.⁴
¹Clinical Chemistry and Immunology Laboratories, Synlab Diagnostic Centre, Budapest, ²Faculty of Health Science, University of Pecs, ³Department of General Internal Medicine, Markusovszky University Teaching Hospital Szombathely ⁴Department of General Internal Medicine of Medical Centre, Hungarian Defence Forces Budapest, Hungary

PS2.11 Multiplex anti-cytokine autoantibody detection during pregnancy
Erdő-Bonyár S., Simon D., Bajnok A., Nörenberg J., Serény-Litvai T., Várnagy Á., Kovács K., Hantosi E., Mezősi E., Berki T.
National Laboratory on Human Reproduction, University of Pécs, Pécs, Hungary

PS2.12 ELISA methods for the determination of anti-PEG antibodies
Katona É.¹, Szeles S.¹, Molnár É.¹, Nemes L.², Bereczky Z.¹
¹Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, ²Medical Center of Hungarian Defense Forces, Budapest, Hungary

PS2.13 Interfering effect of high serum glucose levels in clinical chemistry assays
Süki N., Kacz-Buzer K., Szakony S.
St Imre Teaching Hospital, Central Laboratory, Budapest, Hungary

PS2.14 Laboratory algorithm for the suspected presence of macrohormones.
Hadházi D., Kalina E., Kappelmayer J., Bhattoa HP.
Department of Laboratory Medicine, Faculty of Medicine, University of Medicine, Debrecen, Hungary

PS2.15 Macro-CK determination at the Department of Laboratory Medicine in Debrecen: a retrospective analysis of 11 years
Bencze D.¹, Tóth J.¹, Mosolygó-Lukács Á.¹, Kalina E,¹, Kassai P.², Kappelmayer J.¹
¹Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Hungary
² ESZFK Nonprofit Kft, Budapest, Hungary

PS2.16 Prealbumin levels correlate with acute phase proteins in patient groups with severe illness
Varga Z., Lakatos K.
National Institute of Oncology, Central Laboratory, Budapest, Hungary

14:35-14:50 SZÜNET, MŰSZERKIÁLLÍTÁS MEGTEKINTÉSE

Párhuzamos szekciók:

14:50-16:10 POSZTERSZEKCIÓ III. (Helyszín: Nagyvárad tér, Tanácsterem)
PS3.1-16 Poszterzsűri: Hevessy Zsuzsanna, Nagy Tamás

PS3.1 Newborn screening of cystic fibrosis in Hungary – experience from 2022
Lénárt I., Kósa M., Szabó H., Bereczki C., Monostori P.
University of Szeged, Department of Pediatrics, Szeged, Hungary

PS3.2 Heterozygote prevalence among Leiden mutation tests requested by obstetricians and gynecologists
Balogh E., Lanther L, Csókay B., Fodor F.
Synlab Hungary Ltd., Laboratory of Molecular Diagnostics, Budapest, Hungary

PS3.3 Sensitive quantitative PCR system for monitoring measurable residual disease from peripheral blood samples in multiple myeloma patients carrying IGH::NSD2 gene fusion
Bors A, Kozma A., Hardi A., Csabán D., Őrfi Z., Tankó L., Tomán Á., Harasztdombi J., Dolgos J., Reichardt J., Vályi-Nagy I., Reményi P., Mikala G., Andrikovics H.
Central Hospital of Southern Pest, Budapest, Hungary

PS3.4 Somatic hypermutation status determination in CLL: methodological considerations
Csabán D., Mátrai Z., Reichardt J., Mikala G., Fábián J., Lakatos V., Andrikovics H., Bors A.
Central Hospital of Southern Pest, Budapest, Hungary

PS3.5 Investigation of memory and behavior relationships in C57BL/6 and Tac4 gene-deficient mice
Asztalos-Kovács A.¹, Kepe E.², Helyes Z.^2,3, Borbély É.²
¹Bács-Kiskun County Teaching Hospital, University of Szeged, Kecskemét, Hungary, ²Department of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Pécs, Hungary, ³Eötvös Loránd Research Network, Chronic Pain Research Group, University of Pécs, Hungary

PS3.6 The association between EPCR p.Ser219Gly polymorphism and venous thrombosis risk: a case-control study and meta-analysis
Pituk D., Miklós T., Bereczky Z.
Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

PS3.7 Molecular cytogenetic analysis of enriched CD138+ plasma cells in newly diagnosed multiple myeloma
Kozma A.¹, Tomán Á.¹, Nagy A.¹, Kondor N.¹, Heincz Z.¹, Kovács A.¹, Bors A.¹, Reményi P.², Mikala G.², Andrikovics H.¹
¹Central Hospital of Southern Pest – National Institute of Hematology and Infectious Diseases, Laboratory of Molecular Genetics, ²Department of Hematology and Stem Cell Transplantation, Budapest, Hungary

PS3.8 Bedside diagnostics of SARS-CoV-2 infection with the Vivalytic PCR analyzer
Földesi R.¹, Csoma E.², Ujvárosy D.³, Reiger Z.⁴, Kovács C.⁵, Antal-Szalmás P.¹, Kappelmayer J.¹
University Debrecen, ¹Department Laboratory Medicine, ²Department Medical Microbiology, ³Emergency Clinic, ⁴Department Infectious Diseases of the Pediatric Clinic, ⁵Emergency Department Gyula Kenézy Campus, Debrecen, Hungary

PS3.9 Characteristics of clinical laboratory sample transport by pneumatic tube systems in Hungary
Kappelmayer J and Tóth J on behalf of the laboratories responding to the preanalytical questionnaire about clinical laboratory sample transport.
Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Hungary

PS3.10 Streptococcus agalactiae detection rates in relation to different sampling methods of pregnant females
Kovács D., Papp K., Ajzner É.
University Teaching Hospital of Szabolcs-Szatmár-Bereg County, Jósa University Hospital, Central Laboratory, Nyíregyháza, Hungary

PS3.11 Review of critical risk result list in four satellite laboratories of the laboratory network in Szabolcs-Szatmár-Bereg County
Kovácsné Salagvárdi L.¹, Kocsis A.¹, Ajzner É.²
Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház, Department of Laboratory, Fehérgyarmat-Mátészalka-Vásárosnamény-Nyírbátor1, Nyíregyháza2, Hungary

PS3.12 Integrated operation of laboratory network of Szabolcs-Szatmár-Bereg County
Kocsis A.¹, Ajzner É.²
Szabolcs-Szatmár-Bereg megyei Kórházak és Egyetemi Oktatókórház, Medical Laboratory, Fehérgyarmat-Mátészalka-Vásárosnamény-Nyírbátor¹, Nagykálló-Nyíregyháza², Hungary

PS3.13 Effect of temperature on the results of individual analytes
Farkas M., Sipos L.
Synlab Hungary Ltd., Székesfehérvár, Hungary

PS3.14 Evaluation of Acceptability of a Reagent Lot Change
Szurovecz M., Kacz-Buzer K., Pákozdi B., Szakony S.
St. Imre Teaching Hospital, Central Laboratory, Budapest, Hungary

PS3.15 Quality indicators: summary of 10 years of experience
Spitzer N., Jécsák-Pap J., Szakony S.
St Imre Teaching Hospital, Central Laboratory, Budapest, Hungary

PS3.16 Daratumumab interference during multiple myeloma monitoring – single center experience
Sipos-Dudás E.¹, Lakatos K.²
¹Vaszary Kolos Hospital, Central Laboratory, Esztergom, Hungary, ²National Institute of Oncology, Clinical Central Laboratory, Budapest, Hungary

14:50-16:15 POSZTERSZEKCIÓ IV. (Helyszín: Nagyvárad tér, Tanácsterem)
PS4.1-17 Poszterzsűri: Seres Erika, Simon Ágnes

PS4.1 Renal stone analyis by Fourier Transform Spectroscopy
Walentin S., Magyar A., Kleiber M., Imreh É.
Semmelwis University, Szent Rókus Laboratory, Budapest, Hungary

PS4.2 The importance of fecal flora in gastrointestinal illness
Kádár K.B., Jakab M., Pintér E.
SYNLAB Hungary Ltd., Clinical Chemistry and Immunology Laboratory, Budapest, Hungary

PS4.3 Measuring the Enhanced Liver Fibrosis (ELF) score in a clinical chemistry laboratory
Péntek J., Bakó F., Bekő G.
Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Central Laboratory, Budapest, Hungary

PS4.4 Affinity investigation of anti-SARS-COV-2 immunoglobulins in myositis patients receiving immunosuppressant therapy
Forray M.¹, Nagy B. Jr.², Griger Z.³, Kappelmayer J.², Pénzes-D.K.¹
¹Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Laboratory Science, University of Debrecen, Debrecen; ²Faculty of Medicine, Department of Laboratory Medicine, University of Debrecen, Debrecen; ³Faculty of Medicine, Division of Clinical Immunology, University of Debrecen, Debrecen

PS4.5 Case report: Unusual Polymicrobial Brain Abscess
Nagy T., Erőss A., Murvai B.L., Mózes M., Gábor S.M., Biró Z., Antal I., Kalmár T.P., Tóth B.I., Méri A., Simon J., Jäckel M.
Central Hospital of Northern Pest – Military Hospital, Budapest, Hungary

PS4.6 Are we thinking about transfusion-induced hemolysis in case of transfusion of selected blood product?
Egervari E.¹, Fodor B.^1,2
¹BAZ Count Hospital and University Hospital, Department of Laboratory Medicine, ²University of Miskolc, Faculty of Health Sciences, Miskolc, Hungary

PS4.7 Investigation of interdependence between fecal zonulin level and immune response to common food antigens
Késmárki-Tőzsér L., Pintér E.
SYNLAB Hungary Ltd., Diagnostic Center Clinical Chemistry and Immunological Department, Budapest, Hungary

PS4.8 Serum total antioxidant capacity/lymphocyte ratio with potential predictive value in COVID-19
Horváth-Szalai Z.^1,4, Csepregi R.^1,4, Szirmay B.^1,4, Sipos D.³, Péterfalvi Á.¹, Tóth I.², Csontos C.², Kovács L.G.^1,4, Miseta A.¹, Kőszegi T.^1,4

PS4.9 Re-emerging old psychoactive agent: kratom
Lakatos Á., Lelovics V., Hesszenberger D., Mayer M., Lajtai A.
University of Pécs, Medical School, Department of Laboratory Medicine, Pécs, Hungary

PS4.10 Optimization of Complex Regional Pain Syndrome passive transfer-trauma mouse model
Dömötör E.^1,4, Szentes N.¹, Sensi S.², Neiland H.², Goebel A.², Tékus V.¹, Helyes Z.^1,3
¹Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Hungary, ²Pain Research Institute, University of Liverpool, United Kingdom, ³PharmInVivo Ltd., H-7629, Pécs, Hungary, ⁴Bács-Kiskun County Teaching Hospital, University of Szeged, Kecskemét; Hungary

PS4.11 A potential killer: Amlodipine
Lajtai A., Hesszenberger D., Lakatos Á., Csabai D., Mayer M., Kuzma M.
University of Pécs, Medical School, Department of Laboratory Medicine, Pécs, Hungary

PS4.12 Potential non-specific side effects of anti-viral vaccines? – A study on the suspected dynamic plasticity of natural autoantibodies in the post-COVID era
Böröcz K., Szinger D., Simon D., Erdő-Bonyár S., Németh P., Berki T.
Department of Immunology and Biotechnology, Clinical Center, University of Pécs Medical School, Pécs, Hungary

PS4.13 The diagnostic and prognostic role of urinary protein markers in patients presented to the emergency department with SARS-CoV-2 infection
Szirmay B.¹, Horváth-Szalai Z.¹, Ludány A.¹, Miseta A.¹, Wittmann I.², Kőszegi T.¹
¹Department of Laboratory Medicine, University of Pécs, Pécs, Hungary
²2nd Department of Internal Medicine and Nephrology-Diabetes Center, University of Pécs, Pécs, Hungary

PS4.14 A simple and cost-effective HPLC-UV method for determining levetiracetam in plasma samples
Pribér J., Tisza K., Bekő G.
Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary

PS4.15 Examination of the serum SARS-CoV-2 S protein IgG antibody level of healthcare workers
Sárközi-Pál E.G., Ivanciuc S., Szoboszlay I.
Markhot Ferenc Teaching Hospital, Central Laboratory, Eger, Hungary

PS4.16 Our experience with the automated AESKU HELIOS® system
Vietorisz I., Bekő G.
Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Central Laboratory, Budapest, Hungary

PS4.17 A liquid chromatography-tandem mass spectrometry method for the therapeutic monitoring of colistin concentrations in critically ill patients
Farkas R.¹, Kesztyűs V.², Csöndör É.1, Bocskai K.¹, Gulyás E.³, Karvaly G.¹
¹Semmelweis University, Department of Laboratory Medicine, ²Semmelweis University, Department of Anesthesiology and Intensive Care, ³Semmelweis University, Department of Pharmacy and Pharmacy Administration, Budapest, Hungary

SZÜNET (15 PERC)

16.30-17:45 Varia szekció (helyszín: Díszterem)
Üléselnökök: Szakony Szilvia – Amir Houshang Shemirani

SE5.1 The devil is in the details: Eliminating false metagenomic classification with a novel algorithm
Takács B.1^,2, Jaksa G.², Qorri E.¹, Gyuris Z.², Pintér L.¹, Haracska L.^1,2
¹Biological Research Centre, Institute of Genetics, Szeged, Hungary, ²Delta Bio 2000 Ltd, Szeged, Hungary

SE5.2 Liquid biopsy-based monitoring of estrogen receptor mutation in breast cancer
Priskin K.¹, Giricz Z.², Pintér L.¹, Jaksa G.¹, Csányi B.¹, Enyedi MZ.¹, Sükösd F.³, Kahán Z.⁴, Haracska L.¹
¹Delta Bio 2000 Kft., Szeged, Hungary, ²European Life Technologies Hungary Kft., Szeged, Hungary ³Albert Szent-Györgyi Health Centre, Department of Pathology, Szeged, Hungary, ⁴ Albert Szent-Györgyi Health Centre, Department of Oncology, Szeged, Hungary

SE5.3 The impact of red blood cell parameters on Hemoglobin A1c levels.
Nagy T., Nagy Z., Miseta A.
University of Pécs, Medical School, Dept. of Laboratory Medicine, Pécs, Hungary.

SE5.4 Partial myeloperoxidase deficiency as a potential prognostic marker in a patient with essential thrombocythemia associated with a rare calreticulin mutation
Kárai B.¹, Palicskó B.¹, Ujfalusi A.¹, Gergely L.², Kappelmayer J.¹, Hevessy Z. ¹
¹Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, ² Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

SE5.5 The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience
Shemirani A.H.¹, Nagy I.², Barath B.R.², Mango K.², Monostory K.², Nemes B.²
¹Division of Clinical Laboratory Science, Department of Laboratory Medicine, ²Department of Transplantation, Institute of Surgery University of Debrecen, Debrecen, Hungary

19:30 – 02:00 GÁLAVACSORA (helyszín: Ludovika Aréna)

2023. június 10. (szombat)

9:00-10:15 Immunológia-Endokrinológia szekció (IE) (helyszín: Nagyvárad tér, Díszterem)
Üléselnökök: Kőszegi Tamás – Antal-Szalmás Péter

SE6.1 Biomarkers in the laboratory diagnosis of allergy
Fodor B.
BAZ county Hospital and University Hospital, Department of Laboratory Medicine, Faculty of Health Sciences, University of Miskolc, Hungary

SE6.2 Immunology test request of Assisted Reproduction Center, Semmelweis University
Szabó Z.¹, Barabás E.¹, Beleznay Z.¹, Vass K.C.¹, Antritter Z.², Lajtai K.², Sajgó A.², Várbíró S.², Vesztergom D.², Sipos M.²
¹Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary, ²Center for Assisted Reproduction, Semmelwei Egyetem, Budapest, Hungary

SE6.3 Endogenous steroid homeostasis response of professional male adult athletes to extreme mental stress
Csöndör É.¹, Karvaly G.¹, Kovács K.¹, Tóth M.^1,2,3
1Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary, 2Faculty of Health Sciences, University of Pécs, Pécs, Hungary, 3University of Physical Education, Budapest, Hungary

SE6.4 Presence of a protein fraction with abnormal binding capacity can cause misleadingly high free T4 and T3 results
Toldy E.^1,2, Konderák J.¹, Kispál R.P.¹, Lőcsei Z.³, Bénik T.⁴
¹Clinical Chemistry and Immunology Laboratories, Synlab Diagnostic Centre, Budapest, ²Faculty of Health Science, University of Pecs, ³Department of General Internal Medicine, Markusovszky University Teaching Hospital Szombathely, ⁴Department of General Internal Medicine of Javorszky Hospital, Vác, Hungary

SE6.5 Laboratory findings in condition of weightness during space travel
Schlégl Ádám
Semmelweis University, Department of Ortopedics, Budapest, Hungary

10:15-10:45 Biomarker szimpózium (helyszín: Nagyvárad tér, Díszterem)
SY1.3 Diagnostics of the future
Eric Jan
Biomarker Kft.

SZÜNET

11:00-11:30 Roche szimpózium (helyszín: Nagyvárad tér, Díszterem)
SY1.4 Digitalizáció és laboratóriumi akkreditáció. Hogyan tudják a gyártók támogatni a laboratóriumi minőségirányítást és akkreditációt?
Dr. Nagy Erzsébet
Hospitaller Order of Saint John of God, Hospital Buda, Budapest, Hungary

11:30-13:00 NOLD KEREKASZTAL (helyszín: Nagyvárad tér, Díszterem)
Moderátorok: Vásárhelyi Barna, Miseta Attila, Kappelmayer János, Földesi Imre, Ajzner Éva, Fodor Bertalan

13:00-13:30 A konferencia zárása, Poszterdíjak átadása (I., II., III. díj, elnöki különdíj)
Záró beszédek – Miseta Attila, Vásárhelyi Barna

13:30 – Ebéd, hazautazás

Az MLDT (Magyar Labordiagnosztikai Társaság) 61. Nagygyűlése 2023. június 6-8. között kerül megrendezésre Budapesten. A társaság elnöksége korlátozott számban pályázatot hirdet a rendezvényen való részvétel költségeinek (regisztrációs díj és/vagy szállásdíj költsége) elengedésére. A pályázat elbírálása az MLDT vezetőségének belső szabályai alapján történik.

A pályázathoz pontosan kitöltve mellékelni kell az alábbi jelentkezési lapot és a pályázónak egyértelműen jeleznie kell, hogy melyik költség elengedésére pályázik.

>>> PÁLYÁZATI FELHÍVÁS (DOC)

Pályázatot beküldhet a laborvezető támogatásával az az orvos, gyógyszerész, klinikai biokémikus, vegyész és biológus, aki MLDT tag.

Beküldési határidő: 2023. május 31.

Beküldés: info@regio10.hu